Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$36,921,375
+$8,935,197 QoQ
Shares Held
146,723
+14.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#435
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $242,744,034 across 9 Drug Manufacturers - General names. ABBV ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
452,664 | $58,167,324 | |
| 2 | JNJ |
Johnson & Johnson
|
211,287 | $53,660,559 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
146,723 | $36,921,375 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
558,264 | $32,167,171 | |
| 5 | PFE |
Pfizer Inc
|
1,137,828 | $27,398,898 | |
| 6 | LLY |
ELI LILLY & Co
|
14,911 | $17,884,702 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
67,881 | $8,576,085 | |
| 8 | AMGN |
Amgen Inc
|
20,994 | $7,602,347 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,921,375 | 146,723 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $27,986,178 | 128,678 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $27,804,491 | 121,688 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $28,217,085 | 121,867 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $30,842,804 | 166,161 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $32,996,885 | 157,488 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $32,469,699 | 182,722 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $33,021,815 | 167,216 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $34,576,373 | 201,588 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $35,875,703 | 197,011 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $34,573,961 | 223,101 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $33,825,142 | 226,923 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $32,094,033 | 238,210 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $37,835,553 | 237,407 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $37,822,557 | 234,036 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $34,902,651 | 260,060 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,775,228 | 246,639 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $32,542,771 | 200,745 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $31,159,872 | 230,132 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $25,342,869 | 234,939 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $25,992,355 | 230,756 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $24,591,695 | 227,238 | Shares | Other | 2021-05-07 | |
| 2020-12-31 | $22,361,133 | 208,690 | Shares | Other | 2021-02-03 | |
| 2020-09-30 | $19,262,616 | 219,918 | Shares | Other | 2020-11-05 | |
| 2020-06-30 | $22,434,129 | 228,500 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $22,001,766 | 288,775 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||